4547.T
4547.T
JP3240600001
KISSEI PHARMACEUTICAL CO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 97.406.000.000 88.330.000.000
10.3%
Cost of Revenue 51.587.000.000 44.265.000.000
16.5%
Gross Profit 45.818.000.000 44.065.000.000
4.0%
48.745.000.000 38.291.000.000
27.3%
Operating Income -2.927.000.000 5.774.000.000
150.7%
Pretax Income 16.891.000.000 15.610.000.000
8.2%
Net Income Common Stockholders 13.779.000.000 11.961.000.000
15.2%
-- --
--
-- --
--
ende